State abortion data is confirming that chemical abortion use is on the rise, as unregulated virtual abortion pill dispensaries also increase since the Food and Drug Administration’s (FDA) decision to weaken safety regulations (REMS) for the abortion pill mifepristone.
By Julia Harte (Reuters) - U.S. telehealth abortion providers scrambled on Thursday to keep their services available after a federal appeals court rul.
US telehealth and in-person abortion providers scrambled on Thursday to keep medication abortion services available after a federal appeals court ruled that mifepristone could be distributed amid ongoing litigation but with significant restrictions.